E2F1 selects tumour cells for both life and death

Journal of Pathology

Volumn 198, Issue 2, 2002, Pages 139-141

  Wyllie, Andrew H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; E2F1; G1 S phase

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL FATE; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOLECULAR INTERACTION; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR CELL;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 0036772636     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1238     Document Type: Article

References (18)

1. Gorgoulis VG, Zacharatos P, Mariatos G, et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinoma. J Pathol 2002; 198: 142-156.
2. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3: 11-20.
3. Wu L, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001; 414: 457-462.
4. Ishida S, Huang E, Zuzan H, et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 2001; 21: 4684-4699.
5. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994; 91: 3602-3606.
6. Hiebert SW, et al. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol 1995; 15: 6864-6874.
7. Hsieh JK, Fredersdorf S, Kouzarides T, et al. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 1997; 11: 1840-1852.
8. Raveh T, Droguett G, Horwitz MS, et al. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 2001; 3: 1-7.
9. Phillips AC, Ernst MK, Bates S, et al. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 1999; 4: 771-81.
10. Elliott MJ, Dong YB, Yang H, McMasters KM. E2F-1 upregulates c-Myc and p14 (ARF) and induces apoptosis in colon cancer cells. Clin Cancer Res 2001; 7: 3590-3597.
11. Evan G, Wyllie AH, Gilbert C, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
12. Leone G, Sears R, Huang E, et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 2001; 8: 105-113.
13. Ho GH, Calvano JE, Bisogna M, Van Zee KJ. Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas. Breast Cancer Res Treat 2001; 69: 115-122.
14. Tang X, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in Stage I non-small-cell lung cancer. J Natl Cancer Inst 2000; 92: 1511-1516.
15. INK4A and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status. Int J Cancer 2000; 89: 133-141.
16. Nicholson SA, Okby NT, Khan MA, et al. Alteration of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small-cell lung carcinoma. Cancer Res 2001; 61: 5636-5643.
17. Mason SL, Loughran O, La Thangue NB. P14 (ARF) regulates E2F activity. Oncogene 2002; 21: 4220-4230.
18. Dong YB, Yang HL, Elliott MJ, McMasters KM. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Cancer Res 2002; 62: 1776-1783.